preprint · SSRN Electronic Journal

Effectiveness and Safety of a Shortened Oral Regimen for Rifampicin- or Multidrug-Resistant Tuberculosis in Peru

Edwin H. Herrera-Flores
Matthew L. Romo
Maricela Curisinche-Rojas
Allison LaHood
Elna Osso
Carole D. Mitnick
Leonid Lecca
Dante Vargas
Michael Rich
Judith Jiménez
Félix Llanos-Tejada
Molly F. Franke
Dalia Guerra
Kwonjune J. Seung
Edmund Shen
Zully M. Puyen-Guerra
Letizia Trevisi
Zully Ruiz-Vargas
José Cornejo-García
Denisse Vela-Trejo
Valentina Alarcon-Guizado

2025Open accessUniversity Of Global Health Equity

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Tuberculosis Research and Epidemiology
Biosimilars and Bioanalytical Methods
Infectious Diseases and Tuberculosis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2139/ssrn.5397503

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.